Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | -1.64% | -1.96% | -6.83% |
04-30 | B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
04-29 | HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.83% | 212M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Oppenheimer Initiates Coverage on Ovid Therapeutics With Outperform Rating, $8 Price Target